(2504–2523) Vasculitis – ANCA-Associated Poster III

Tuesday, October 28, 2025

10:30 AM - 12:30 PM Central Time

Location: Hall F1

CE: 0.00

Presentations:

10:30 AM - 12:30 PM Central Time

Contribution of the CALLY index at diagnosis to early prediction of all-cause mortality in patients with ANCA-associated vasculitis
Abstract Poster Presenter: Jang Woo Ha, MD – Yonsei university college of medicine
10:30 AM - 12:30 PM Central Time

Predictors of Glucocorticoid-Free Clinical Remission at Week 48 in Newly Diagnosed Microscopic Polyangiitis and Granulomatosis with Polyangiitis: from nation-wide registry in Japan (J-CANVAS)
Abstract Poster Presenter: Yusuke Ushio, MD – Division of Hematology, Rheumatology and Respiratory Medicine, Department of Internal Medicine, Faculty of Medicine, Kagawa University
10:30 AM - 12:30 PM Central Time

Beyond Clinical trials in Eosinophilic Granulomatosis with Polyangiitis: A Systematic Review of effectiveness and safety data derived from real-world evidence of Mepolizumab 300 mg
Abstract Poster Presenter: Maria Cid, MD (she/her/hers) – Hospital Clinic Barcelona. University of Barcelona
10:30 AM - 12:30 PM Central Time

Reporting of infectious and hepatic adverse events with avacopan: insights from the World Health Organization pharmacovigilance database (VigiBase)
Abstract Poster Presenter: Camille Mettler, MD – APHP, Service de Médecine Interne, Hôpital Bichat
10:30 AM - 12:30 PM Central Time

A Disproportionality Analysis of FDA Adverse Event Reporting System (FAERS) Events for Avacopan
Abstract Poster Presenter: Shiamak Cooper, MD – Rochester General Hospital
10:30 AM - 12:30 PM Central Time

Avacopan is Not Associated With An Increased Risk of Infection Compared to Glucocorticoids in Patients with ANCA-Associated Vasculitis
Abstract Poster Presenter: Beatriz Maria Franco Hondermann, MD (she/her/hers) – Loyola University Medical Center
10:30 AM - 12:30 PM Central Time

Impact of psychiatric comorbidity on disease outcomes in ANCA-associated vasculitis: A multi-center retrospective cohort study
Abstract Poster Presenter: Saloni Patel, BS (she/her/hers) – Johns Hopkins University School of Medicine
10:30 AM - 12:30 PM Central Time

Timing, Management, and Outcomes of Venous Thromboembolic Events in ANCA-Associated Vasculitis: A Retrospective Cohort Study
Abstract Poster Presenter: Bruno Marchetti, MD – Internal Medicine, Turin
10:30 AM - 12:30 PM Central Time

Patient-Reported Outcomes in ANCA-Associated Vasculitis: Early Findings from a Prospective Real-World Cohort
Abstract Poster Presenter: Colebrook Johnson, BA – Massachusetts General Hospital
10:30 AM - 12:30 PM Central Time

Comparison of Demographics and Outcomes of Inpatient Hospitalization of Severe Asthma Patients with Eosinophilic Granulomatosis with Polyangitis. A Study on the National Inpatient Sample Database
Abstract Poster Presenter: Prakriti Subedi, MD – St. Barnabas Hospital
10:30 AM - 12:30 PM Central Time

Evolution in Risk Stratification for Renal Outcomes in ANCA-Associated Vasculitides Using Established Scores and Histopathological Criteria in a Large European Cohort
Abstract Poster Presenter: Thomas Neumann, MD – Kantonsspital St. Gallen
10:30 AM - 12:30 PM Central Time

DANGER Score as Predictor of Mortality in ANCA-Associated Vasculitis with or without Glomerulonephritis: Data from the Almenara Vasculitis Cohort
Abstract Poster Presenter: Victor Pimentel-Quiroz, MD (he/him/his) – Universidad Científica del Sur
10:30 AM - 12:30 PM Central Time

Impact of ANCA specificity on risk of severe infection occurrence in ANCA-associated vasculitis.
Abstract Poster Presenter: Gregory Pugnet, MD,PhD (he/him/his) – CHU Toulouse Rangueil Service de Medecine Interne et Immunologie Clinique
10:30 AM - 12:30 PM Central Time

Clinical Outcomes and Prognostic Impact of Cardiac and Cerebrovascular Involvement in Eosinophilic Granulomatosis with Polyangiitis: A Retrospective Study
Abstract Poster Presenter: Yuko Shirota, MD., PhD., – Tohoku Medical and Pharmaceutical University / Department of Hematology and Rheumatology
10:30 AM - 12:30 PM Central Time

Variables Associated with In-Hospital Mortality in Adult Eosinophilic Granulomatosis with Polyangiitis from the National Inpatient Sample Database 2017-2021
Abstract Poster Presenter: Anuya Natu, MBBS – John H Stroger, Jr. Hospital of Cook County
10:30 AM - 12:30 PM Central Time

Predictors for Mortality in Patients Who Received Plasmapheresis for Diffuse Alveolar Hemorrhage in ANCA-Associated Vasculitis
Abstract Poster Presenter: Sai Shanmukha Sreeram Pannala, MD (he/him/his) – Northwell Health/Staten Island University Hospital
10:30 AM - 12:30 PM Central Time

Mortality Trends in Primary Systemic Vasculitis in the United States (1999–2023)
Abstract Poster Presenter: Sabah Mohib, MBBS – Dow Medical College
10:30 AM - 12:30 PM Central Time

The SHIPE index: A tertile-based approach to predict end-stage kidney disease in ANCA-associated vasculitis
Abstract Poster Presenter: HYUNSUE DO, MD – Kangwon national university hospital
10:30 AM - 12:30 PM Central Time

The Association Between Neurologic Involvement and Cumulative Damage in ANCA-Associated Vasculitis
Abstract Poster Presenter: Ruoning (Lemon) Ni, MD, RhMSUS (she/her/hers) – University of Iowa
10:30 AM - 12:30 PM Central Time

Predicting future relapse with proteomics in ANCA-Associated Vasculitis
Abstract Poster Presenter: Evan Barnes, MD, MS – Massachusetts General Hospital